Editors' picks of pharmaceutical science & technology innovations - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Editors' picks of pharmaceutical science & technology innovations
The latest in automation/IT/process control

Pharmaceutical Technology
Volume 37, Issue 7, pp. 18

Process modeling and manufacturing software features a Web-based user interface



The aspenONE software from Aspen Technology incorporates Aspen Plus, Aspen HYSYS, and any data historian into a Web interface that allows users to work with the software through Web-enabled devices. The interface gives users easy access to models and real-time plant information. The software can be used to compare model predictions and actual plant data and to conduct what-if scenarios for troubleshooting or optimizing. The software features a simple user interface and does not require specialized training. The software's search engine is designed for the process industries and enables users to find specific process information from across an enterprise in seconds.

Aspen Technology
http://www.aspentech.com/

Scientific innovation lifecycle management software manages large datasets



Accelrys Enterprise Platform 9.0 is an open, scientifically aware platform capable of managing "big data" and externalized research-collaboration networks. The platform offers enhancements in security, administration, and scientific services, which give organizations new tools for streamlining the lab-to-commercialization value chain and driving innovation in new product development. New capabilities allow for flexible administration and Internet deployments of clients outside of an organization's firewall with enhanced security, which enables secure and efficient interaction with external partners. The platform also offers broad scientific collections that are capable of handling structured and unstructured data, biological sequences, chemical structures, images, and text. The platform's reporting capabilities enable end-users to interpret and interact with data to drive more informed decision-making.

Accelrys
http://www.accelrys.com/


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here